๐ฌ New vaccine approach targets TB's dangerous proteins
Tuberculosis, a major global killer, is being tackled with a new vaccine candidate designed using immunoinformatic techniques. Researchers developed this multi-epitope subunit vaccine (MESV) targeting five virulence-associated proteins from Mycobacterium tuberculosis. The study involved rigorous testing, confirming the MESV's stability and strong binding affinity to TLR4 receptors. This promising candidate could potentially generate powerful humoral and cellular immune responses against the disease. Further experimental validation is now required to see its real-world impact. ๐ฌ